NEW YORK (GenomeWeb News) - Luminex last week said first-quarter revenue increased 28 percent as R&D spending rose 23 percent and profit shrank by 75 percent.

 

Total receipts for the three months ended March 31, 2007, increased to $16.6 million from $13 million year over year. Results included one month of revenues from Tm Bioscience, which Luminex acquired on March 1 and has renamed Luminex Molecular Diagnostics.